- Home
- TECH
TECH
Bio-Techne Corp
as 12-20-2024 4:00pm EST
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 11.3B | IPO Year: | 1989 |
| Target Price: | $82.00 | AVG Volume (30 days): | 795.5K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.95 | EPS Growth: | -37.52 |
| 52 Week Low/High: | $61.16 - $85.57 | Next Earning Date: | 01-30-2025 |
| Revenue: | $1,171,583,000 | Revenue Growth: | 2.41% |
| Revenue Growth (this year): | 7.67% | Revenue Growth (next year): | 9.38% |
Latest Bio-Techne Corp News
TECH Breaking Stock News: Dive into TECH Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
MT Newswires
3 days ago
Bio-Techne, Waters Strike Co-Marketing, Co-Promotion Deal
PR Newswire
3 days ago
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
PR Newswire
4 days ago
ScaleReady awards a G-Rex® Grant to Moonlight Bio
MT Newswires
10 days ago
Bio-Techne Signs Distribution Deal With MedSanTek to Expand Product Reach in Turkey
Zacks
10 days ago
Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?
PR Newswire
10 days ago
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
PR Newswire
12 days ago
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
Compare TECH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TECH Bio-Techne Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.